NCT02605044View on ClinicalTrials.gov

Masitinib in Combination With FOLFIRI for Second-line Treatment of Patients With Metastatic Colorectal Cancer

PHASE3TerminatedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Metastatic Colorectal Cancer
Interventions
DRUG

Masitinib (AB1010)

DRUG

FOLFIRI

Trial Locations (3)

75

Hopital Europeen George Pomipidou, Hepato-Gastro-enterologie, 20 rue Leblanc, Paris

169610

National Cancer Center, 11 Hospital Drive, Singapore

W12 0HS

Hammersmith Hospital, Department of Cancer Medicine, Imperial College Healthcare Trust, Du Cane Road, London

Sponsors

Lead Sponsor

AB Science
All Listed Sponsors
lead

AB Science

INDUSTRY